Published 19 days ago

Can investing in infectious disease pay off? Vir Biotechnology's tightrope walk shows it's a struggle

Summary by STAT

In 2017, Vir's founders threw millions at infectious disease. Covid made them look like geniuses. The road since then has been far rockier.

0 Articles

All

Left

Center

Right

In 2017, Vir's founders threw millions at infectious disease. Covid made them look like geniuses. The road since then has been far rockier.

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.

Total News Sources0

Leaning Left0Leaning Right0Center1Last Updated18 days agoBias Distribution

100% Center

100% Center

Factuality

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)